BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$607M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$226M |
| 3 |
SPDR S&P Retail ETF
XRT
|
+$220M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$179M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$131M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Tesla
TSLA
|
+$652M |
| 3 |
Microsoft
MSFT
|
+$601M |
| 4 |
Apple
AAPL
|
+$520M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$362M |
Sector Composition
| 1 | Technology | 17.04% |
| 2 | Financials | 11.4% |
| 3 | Healthcare | 8.84% |
| 4 | Consumer Discretionary | 8.27% |
| 5 | Industrials | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Global Water Resources
GWRS
$269M
| $44.7K | ﹤0.01% |
2,386
+1,835
| +333% | +$34.4K |
|
|
ONCT
2802
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $44.6K | ﹤0.01% |
535
+302
| +130% | +$25.2K |
|
|
GSS
2803
DELISTED
Golden Star Resources Ltd.
GSS
| $44.5K | ﹤0.01% |
18,711
+19
| +0.1% | +$45 |
|
2804
United States Lime & Minerals
USLM
$3.64B
| $44.3K | ﹤0.01% |
1,835
-55
| -3% | -$1.33K |
|
|
ICAD
2805
DELISTED
iCAD Inc
ICAD
| $44.3K | ﹤0.01% |
4,119
+3,148
| +324% | +$33.8K |
|
2806
Escalade
ESCA
$173M
| $44.2K | ﹤0.01% |
2,338
+1,619
| +225% | +$30.6K |
|
|
VOXX
2807
DELISTED
VOXX International Corporation Class A
VOXX
| $44.1K | ﹤0.01% |
3,854
+399
| +12% | +$4.57K |
|
2808
InfuSystem Holdings
INFU
$208M
| $44K | ﹤0.01% |
3,378
+2,732
| +423% | +$35.6K |
|
2809
Evolus
EOLS
$475M
| $43.5K | ﹤0.01% |
5,715
+4,375
| +326% | +$33.3K |
|
2810
Cemex
CX
$13.5B
| $43.1K | ﹤0.01% |
6,011
-949
| -14% | -$6.8K |
|
2811
AgEagle Aerial Systems
UAVS
$65.3M
| $43K | ﹤0.01% |
14
+11
| +367% | +$33.8K |
|
|
TRVN
2812
DELISTED
Trevena, Inc.
TRVN
| $42.9K | ﹤0.01% |
56
+46
| +460% | +$35.3K |
|
2813
Eletrobras Common Shares
EBR
$19.3B
| $42.9K | ﹤0.01% |
6,038
+4,218
| +232% | +$29.9K |
|
2814
Mustang Bio
MBIO
$10.6M
| $42.7K | ﹤0.01% |
21
+11
| +110% | +$22.4K |
|
2815
The ONE Group
STKS
$82.3M
| $42.5K | ﹤0.01% |
3,973
+3,220
| +428% | +$34.4K |
|
2816
CorMedix
CRMD
$985M
| $42.2K | ﹤0.01% |
9,066
+5,785
| +176% | +$26.9K |
|
|
ITI
2817
DELISTED
Iteris, Inc.
ITI
| $41.7K | ﹤0.01% |
7,903
+6,395
| +424% | +$33.8K |
|
|
SEEL
2818
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $41.7K | ﹤0.01% |
5
+4
| +400% | +$33.4K |
|
|
IMDX
2819
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$85.3M
| $40.2K | ﹤0.01% |
564
+441
| +359% | +$31.4K |
|
2820
Fortress Biotech
FBIO
$113M
| $40.1K | ﹤0.01% |
831
+633
| +320% | +$30.6K |
|
|
EVLO
2821
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $40.1K | ﹤0.01% |
285
+247
| +650% | +$34.7K |
|
|
PZN
2822
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $40.1K | ﹤0.01% |
4,072
+3,400
| +506% | +$33.5K |
|
2823
KVH Industries
KVHI
$115M
| $39.9K | ﹤0.01% |
4,144
+2,261
| +120% | +$21.8K |
|
2824
Dianthus Therapeutics
DNTH
$1.21B
| $39.8K | ﹤0.01% |
342
+278
| +434% | +$32.4K |
|
2825
Aurinia Pharmaceuticals
AUPH
$1.63B
| $39.7K | ﹤0.01% |
+1,793
| New | +$39.7K |
|